Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

NBI 35965 hydrochloride

Name NBI 35965 hydrochloride
Supplier R&D Systems
Catalog 3100
Prices $205.00, $845.00
Sizes 10 mg, 50 mg
Cas Number 1782228-59-4
Chemical Name (7S)-6-(Cyclopropylmethyl)-2-(2,4-dichlorophenyl)-7-ethyl-7,8-dihydro-4-methyl-6H-1,3,6,8a-tetraazaacenaphthylenehydrochloride
Formula C21H22Cl2N4.HCl
Molecular Weight 437.79
Purity >98%
Supplier Page Shop

Product References

Mechanism of corticotropin-releasing factor type I receptor regulation by - Mechanism of corticotropin-releasing factor type I receptor regulation by

Hoare SR, Sullivan SK, Ling N, Crowe PD, Grigoriadis DE. Mol Pharmacol. 2003 Mar;63(3):751-65.

Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonists. - Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonists.

Gross RS, Guo Z, Dyck B, Coon T, Huang CQ, Lowe RF, Marinkovic D, Moorjani M, Nelson J, Zamani-Kord S, Grigoriadis DE, Hoare SR, Crowe PD, Bu JH, Haddach M, McCarthy J, Saunders J, Sullivan R, Chen T, Williams JP. J Med Chem. 2005 Sep 8;48(18):5780-93.

A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts - A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts

Million M, Grigoriadis DE, Sullivan S, Crowe PD, McRoberts JA, Zhou H, Saunders PR, Maillot C, Mayer EA, Tache Y. Brain Res. 2003 Sep 19;985(1):32-42.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved